Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer

European Journal of Surgical Oncology

Volumn 34, Issue 7, 2008, Pages 805-810

  Marchal, C ^a   Redondo, M ^b   Reyes Engel, A ^c   Perea Milla, E ^b   Gaitan, M J ^c   Machuca, J ^a   Diaz, F ^a   Caballero, J ^b   Carnero, J ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL COSTA DEL SOL   (Spain)

^c UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

Folate metabolism; MTHFR; MTR; MTRR; Prostate cancer

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GENOMIC DNA; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; S ADENOSYLMETHIONINE;

AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FOLATE METABOLISM; GENETIC ASSOCIATION; GENOTYPE; GLEASON SCORE; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; STATISTICAL SIGNIFICANCE;

EID: 44949264116     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.09.008     Document Type: Article

References (36)

1. Frost P., Blom H.J., Gollete P., Sephhard C.A., and Matthews R.G. A candidate genetic risk factor for vascular disease. Nat Genet 10 (1996) 111-113
2. Deloughery T.G., Evans A., Sadeghi A., et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 94 12 (1996) 3074-3078
3. Van der Put N.M., Gabreels F., Stevens E.M., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 5 (1998) 1044-1051
4. Wilson A., Leclerc D., Rosenblatt D.S., and Gravel R.A. Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet 8 11 (1999) 2009-2016
5. Gaughan D.J., Kluitjmans L.A., Barbaux S., et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157 2 (2001) 451-456
6. Pereira T.V., Rudnicki M., Pereira A.C., POmbo-de-Oliveira M.S., and Franco R.F. 5,10 Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leucemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15 10 (2006) 1956-1963
7. Esteller M., Garcia A., Martinez-Palones J.M., Xercavins J., and Reventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18 12 (1997) 2307-2311
8. Ma J., Stampfer M., and Giovannucci E. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57 (1997) 1098-1102
9. Hubner R.A., and Houlston R.S. MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer 120 5 (2007) 1027-1035
10. Le Marchand L., Wilkens L.R., Kolonel L.N., and Henderson B.E. The MTHFR C677T polymorphism and colorectal cancer: a multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14 5 (2005) 1198-1203
11. Nelson W.G., De Marzo A.M., and Isaacs W.B. Prostate cancer. N Engl J Med 349 (2003) 366-381
12. Lee W.H., Isaacs W.B., Bova G.S., and Nelson W.G. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 6 6 (1997) 443-450
13. Heijmans B.T., Jolanda M.A., Boer H., et al. A common variant of the methyltetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 63 (2003) 1249-1253
14. Kimura F., Franke K., Steinhof C., et al. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate 45 (2000) 225-231
15. Cicek M., Nock N., David C., Casey G., and Witte J. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 13 8 (2004) 1331-1336
16. Guelpen B., Wiren S., Bergh A.R., Hallmans G., Stattin P.E., and Hultdin J. Polymorphism of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study. Eur J Cancer Prev 15 1 (2006) 46-50
17. Hultdin J., Guelpen V., Bergh A., Hallmans G., and Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 113 5 (2005) 819-824
18. Chen J., Giovannucci E., Hankinson S.E., et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19 12 (1998) 2129-2132
19. Sharp L., Little J., Schofield A.C., Paulidou E., Cotton S.C., and Miedzybrozka Z. Folate and breast cancer: the role of polymorphisms in the methylenetetrhydrofolate reductase (MTFHR). Cancer Lett 181 (2002) 65-71
20. Skibola C.F., Smith M.T., Kane E., et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A 96 22 (1999) 12810-12815
21. Wiemels J.L., Smith R.N., Taylor G.M., Eden O.B., Alexander F.E., and Greaves M.F. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A 98 7 (2001) 4004-4009
22. Song C., Xing D., Tan W., Wei Q., and Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61 8 (2001) 3272-3275
23. Matsuo K., Suzuki R., Hamajina N., et al. Association between polymorphism of folate and methionine metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97 (2001) 3205-3208
24. Kimura F., Florl A.R., Steinhoff C., et al. Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res 458 1-2 (2001) 49-54
25. Goode E.L., Potter J.D., Bigler J., and Ulrico C. Methionine synthase D919G polymorphism, folate metabolism and colorectal adenoma risk. Cancer Epidemiology Biomarkers Prev 13 (2004) 157-162
26. Matsuo K., Hamajima N., Hirai T., et al. Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 3 (2002) 353-359
27. Le Marchand L., Dolon T., Hankin J., Kolonel L., Wilkens L., and Seifried A. B-vitamin intake, metabolic genes and colorectal cancer risk. Cancer Causes Control 13 (2002) 229-248
28. Kim Y.-I. Folate and carcinogenesis: evidence, mechanism and implications. J Nutr Biochem 10 (1999) 66-88
29. Ulvik A., and Ueland P.M. Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism. Clin Chem 47 11 (2001) 2050-2053
30. Yegnasubramanian S., Kowalski J., Gonzalgo M., et al. Hypermethylation CpG islands in primary and metastatic human prostate cancer. Cancer Res 64 6 (2004) 1975-1986
31. Pavillard V., Drbal A.A., Swaine D.J., Phillips R.M., Double J.A., and Nicolaou A. Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation. Biochem Pharmacol 67 8 (2004) 1587-1599
32. Stankova J., Shang J., and Rozen R. Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo. Clin Cancer Res 11 5 (2005) 2047-2052
33. Zingg J.M., and Jones P.A. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18 5 (1997) 869-882
34. Ryan B.M., Molloy A.M., McManus R., et al. The methylenetetrahydrofolate reductase (MTHFR) gene in colorectal cancer: role in tumor development and significance of allelic loss in tumor progression. Int J Gastrointest Cancer 30 3 (2001) 105-111
35. Singal R., Ferdinand L., Das P.M., Reis I.M., and Schlesselman J.J. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int J Oncol 25 5 (2004) 1465-1471
36. Shrubsole M., Gao T.G., Cai Q., et al. MTR and MTRR polymorphisms dietary intake and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15 (2006) 586-588